Multicenter Randomized Controlled Study of Rosuvastatin for Prevention of Contrast Induced Acute Kidney Injury in Patients With Diabetes and Slight to Moderate Renal Insufficient

Trial Profile

Multicenter Randomized Controlled Study of Rosuvastatin for Prevention of Contrast Induced Acute Kidney Injury in Patients With Diabetes and Slight to Moderate Renal Insufficient

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Mar 2014

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Acute kidney injury
  • Focus Therapeutic Use
  • Acronyms TRACK-D
  • Most Recent Events

    • 28 Mar 2014 New trial record
    • 01 Nov 2011 Primary endpoint 'Serum-creatinine-levels' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top